Dementia Big
The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease.
http://ift.tt/1X0M9HW
No comments:
Post a Comment